Lantus solostar insulin 10ml.vial
Lantus solostar insulin 10ml.vial
The Lantus solostar
insulin 10ml.vial Cartridge System is an innovative delivery system for the
long-acting sort of the hormone insulin. Insulin helps control the quantity of
sugar present within the body by reducing the quantity of glucose within the
blood, a treatment commonly related to diabetes. This delivery system is
employed to enhance glycemic control in both adults and kids diagnosed with
type 1 diabetes, also as in adults diagnosed with type 2 diabetes.
The Lantus
solostar insulin 10ml.vial insulin delivery system should be used once
each day at an equivalent time a day. Confirm the skin area where the injection
is going to be given is clean and dry. Inject slightly below the skin of the
abdomen, upper arms, or thighs, as directed by your doctor. Don’t rub the
injection site before or after the shot. Don’t inject the insulin shot into a
vein or muscle. Change the injection site daily to avoid skin irritation.
Lantus is contraindicated in patients who are hypersensitive
to insulin glargine or one among its components. Lantus should never be diluted
or mixed with the other insulin compound or solution, because the solution may
become cloudy, and this will significantly affect the onset of action of the
answer. Don’t use the other method to administer Lantus, like an insulin pump
or intravenously because severe hypoglycemia may occur. Remember that insulin
devices and needles should never be shared with other patients. Blood sugar
levels in patients treated with insulin should be closely monitored for any
significant changes. A sudden drop in blood glucose levels can indicate
hypoglycemia, which may be dangerous.
Uses and dosage:
Adults and Children:
Given by SC inj once daily at same time each day into abdominal
area, thigh, or deltoid; rotate inj sites. Onset one .1hrs, no pronounced peak,
duration 24hrs or longer. <6yrs: not established. ≥6yrs: individualize;
monitor and adjust as needed. Type 1 diabetes: Initially ⅓ of total daily
insulin dose. Give remainder of the total dose as short-acting, premeal
insulin. Insulin-naïve with type 2 diabetes: Initially 0.2 Units per kg or up
to 10 Units once daily. May need to adjust amount, timing of short- or
rapid-acting insulins and doses of any oral antidiabetics. Switching from
once-daily Toujeo (insulin glargine 300 Units/mL): reduce initial Lantus dose
by 20% of the previous Toujeo dose. Switching from a long- or
intermediate-acting insulin regimen: may need to change basal insulin dose; and
adjust the amount, timing of the short-acting insulins and doses of any oral
antidiabetics. Switching from once-daily NPH: initial Lantus dose should be the
same as previous NPH dose. Switching from twice-daily NPH: reduce initial
Lantus dose by 20% of the previous total NPH dose.
Comments
Post a Comment